Table 1 Characteristics of the study population (N = 21,803), by age groups
Age at inclusion (years) Number of women (N) | 19–39 N = 4916 | 40–54 N = 6726 | ≥55 N = 10,161 | All N = 21,803 | ||||
|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | |
Parity a | ||||||||
 None | 1577 | 32.1 | 402 | 6.0 | 643 | 6.3 | 2622 | 12.0 |
 1 | 712 | 14.5 | 645 | 9.6 | 733 | 7.2 | 2090 | 9.6 |
 2 | 1565 | 31.8 | 2770 | 41.2 | 3296 | 32.4 | 7631 | 35.0 |
  ≥ 3 | 1050 | 21.4 | 2895 | 43.0 | 5472 | 53.9 | 9417 | 43.2 |
Body mass index a | ||||||||
  < 18.5 (underweight) | 72 | 1.5 | 40 | 0.6 | 70 | 0.7 | 182 | 0.8 |
 18.5–24.9 (normal) | 2515 | 51.2 | 2707 | 40.2 | 2991 | 29.4 | 8213 | 37.8 |
 25.0–29.9 (overweight) | 1434 | 29.2 | 2579 | 38.3 | 4245 | 41.8 | 8258 | 38.0 |
  ≥ 30 (obesity) | 879 | 17.9 | 1387 | 20.6 | 2806 | 27.6 | 5072 | 23.3 |
Asthma | 668 | 13.6 | 752 | 11.2 | 1211 | 11.9 | 2631 | 12.1 |
Myocardial infarction | 1 | 0 | 24 | 0.4 | 312 | 3.1 | 337 | 1.5 |
Cerebral stroke | 11 | 0.2 | 72 | 1.1 | 424 | 4.2 | 507 | 2.3 |
Diabetes | 47 | 1.0 | 137 | 2.0 | 672 | 6.6 | 856 | 3.9 |
Continence status a | ||||||||
 Continent | 3800 | 77.3 | 4735 | 70.4 | 6936 | 68.3 | 15,471 | 71.0 |
 Any UI | 1116 | 22.7 | 1991 | 29.6 | 3225 | 31.7 | 6332 | 29.0 |
Type of UI (n = 6332) a | ||||||||
 Stress | 613 | 54.9 | 1015 | 50.9 | 1068 | 33.2 | 2696 | 42.6 |
 Urgency | 136 | 12.2 | 213 | 10.7 | 524 | 16.2 | 873 | 13.8 |
 Mixed | 296 | 26.5 | 705 | 35.4 | 1471 | 45.6 | 2472 | 39.0 |
 Other/unclassified | 68 | 6.1 | 51 | 2.6 | 132 | 4.1 | 251 | 4.0 |
 Missing | 3 | 0.3 | 7 | 0.4 | 30 | 0.9 | 40 | 0.6 |
Severity of UI (n = 6332) a | ||||||||
 Slight | 664 | 59.5 | 959 | 48.2 | 952 | 29.5 | 2575 | 40.7 |
 Moderate | 398 | 35.7 | 888 | 44.6 | 1498 | 46.4 | 2784 | 44.0 |
 Severe | 33 | 3.0 | 89 | 4.5 | 522 | 16.2 | 644 | 10.2 |
 Very severe | 1 | 0.1 | 14 | 0.7 | 101 | 3.1 | 116 | 1,8 |
 Missing | 20 | 1.8 | 41 | 2.1 | 152 | 4.7 | 213 | 3.4 |
Anxiety | ||||||||
 HADS-A 8–10.9 | 569 | 11.6 | 714 | 10.6 | 1106 | 10.9 | 2389 | 11.0 |
  Antidepressant status (n = 2389) a | ||||||||
   Using | 62 | 10.9 | 114 | 16.0 | 211 | 19.1 | 387 | 16.2 |
   Not using | 507 | 89.1 | 600 | 84.0 | 895 | 80.9 | 2002 | 83.8 |
 HADS-A ≥ 11 | 311 | 6.3 | 442 | 6.6 | 563 | 5.5 | 1316 | 6.0 |
  Antidepressant status (n = 1316) a | ||||||||
   Using | 62 | 19.9 | 130 | 29.4 | 197 | 35.0 | 389 | 29.6 |
   Not using | 249 | 80.1 | 312 | 70.6 | 366 | 65.0 | 927 | 70.4 |
Depression | ||||||||
 HADS-D 8–10.9 | 215 | 4.4 | 377 | 5.6 | 839 | 8.3 | 1431 | 6.6 |
  Antidepressant status (n = 1431) a | ||||||||
   Using | 32 | 14.9 | 94 | 24.9 | 178 | 21.2 | 304 | 21.2 |
   Not using | 183 | 85.1 | 283 | 75.1 | 661 | 78.8 | 1127 | 78.8 |
 HADS-D ≥ 11 | 60 | 1.2 | 146 | 2.2 | 240 | 2.4 | 446 | 2.0 |
  Antidepressant status (n = 446)) a | ||||||||
   Using | 21 | 35.0 | 49 | 33.6 | 85 | 35.4 | 155 | 34.8 |
   Not using | 39 | 65.0 | 97 | 66.4 | 155 | 64.6 | 291 | 65.2 |
Psychotropic drug use b | ||||||||
 Opioid analgesics | 245 | 5.0 | 540 | 8.0 | 912 | 9.0 | 1697 | 7.8 |
 Non-opioid analgesics | 136 | 2.8 | 385 | 5.7 | 891 | 8.8 | 1412 | 6.5 |
 Anti-epileptics | 47 | 1.0 | 133 | 2.0 | 213 | 2.1 | 393 | 1.8 |
 Lamotrigin | 21 | 0.4 | 26 | 0.4 | 35 | 0.3 | 82 | 0.4 |
 Anti-parkinson drug | 1 | 0 | 7 | 0.1 | 87 | 0.9 | 95 | 0.4 |
 Anti-psychotics | 34 | 0.7 | 107 | 1.6 | 238 | 2.3 | 379 | 1.7 |
 Anxiolytics | 72 | 1.5 | 283 | 4.2 | 817 | 8.0 | 1172 | 5.4 |
 Hypnotics/sedatives | 91 | 1.9 | 391 | 5.8 | 1693 | 16.7 | 2175 | 10.0 |
 Anti-depressants (all) | 234 | 4.8 | 588 | 8.7 | 1125 | 11.1 | 1947 | 8.9 |
 SSRI | 163 | 3.3 | 358 | 5.3 | 653 | 6.4 | 1174 | 5.4 |